Brode v. Xeris Pharmaceuticals, Inc.

CourtDistrict Court, N.D. Illinois
DecidedMarch 30, 2023
Docket1:22-cv-02903
StatusUnknown

This text of Brode v. Xeris Pharmaceuticals, Inc. (Brode v. Xeris Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brode v. Xeris Pharmaceuticals, Inc., (N.D. Ill. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

ALEXIS BRODE,

Plaintiff, No. 22 CV 2903 v. Judge Manish S. Shah XERIS PHARMACEUTICALS, INC.,

Defendant.

MEMORANDUM OPINION AND ORDER

Plaintiff Alexis Brode filed this lawsuit against former employer, Xeris Pharmaceuticals, Inc., under the American Disabilities Act. Xeris instituted a mandatory COVID-19 vaccine policy in the fall of 2021, and Brode alleges that Xeris regarded her as disabled when it required her to be vaccinated and then discriminated and retaliated against her. Xeris moves to dismiss Brode’s complaint for failure to state a claim, or in the alternative, moves for a more definite statement and to strike. While Brode’s complaint contains allegations that meet some of the elements of her claims, she is missing other required elements, recites legal conclusions, and her allegations are not clear enough to suggest a claim for relief under the ADA. Brode’s complaint is therefore dismissed without prejudice. I. Legal Standard

Under Federal Rule of Civil Procedure 8(a)(2), a complaint must contain “’a short and plain statement of the claim showing that the pleader is entitled to relief,’ in order to ‘give the defendant fair notice of what the claim is and the grounds upon which it rests.’” Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 554–55 (2007) citing Fed. R. Civ. P. 8(a)(2) and Conley v. Gibson, 355 U.S. 41 (1957). A plaintiff must allege

facts that “raise a right to relief above the speculative level” and provide “further factual enhancement to take a claim … from the realm of ‘possibility’ to ‘plausibility.’” Hughes v. Northwestern University, No. 18-2569, 2023 WL 2607921, at *8 (7th Cir. March 23, 2023); see also Swanson v. Citibank, N.A., 614 F.3d 400, 404 (7th Cir. 2010) (“[T]he plaintiff must give enough details about the subject-matter of the case to present a story that holds together.”).

A court reviewing a Rule 12(b)(6) motion to dismiss accepts as true all well- pled facts alleged in the complaint and determines whether “the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Barwin v. Village of Oak Park, 54 F.4th 443, 453 (7th Cir. 2022) citing Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (other citations omitted). “Any document filed pro se is to be liberally construed and a pro se complaint, however inartfully pleaded, must be held to less stringent standards than

formal pleadings drafted by lawyers.” Erickson v. Pardus, 551 U.S. 89, 94 (2007) (internal citations omitted). Even under a liberal construction, however, a litigant must do more than recite the elements of a cause of action or make conclusory statements. See Kaminski v. Elite Staffing, Inc. 23 F.4th 774, 776–77 (7th Cir. 2022) (“All we can do is remind litigants, including those who find themselves having to proceed pro se, that it is not enough for a complaint to allege labels and conclusions with providing facts.”). II. Background

Brode worked as a sales representative at Strongbridge Biopharma from November 2017 until it merged with Xeris in 2021. [3] ¶ 9.1 On October 6, 2021, Xeris had a company-wide call at which it announced that employees were required to get the COVID-19 vaccine. Id. Xeris’s HR department sent several emails following up with reminders to send in proof of vaccination. [3] ¶¶ 11–12. On October 20, 2021, Xeris’s Chief Commercial Officer and Brode had a phone conversation about the company’s vaccine mandate. [3] ¶ 13. Brode expressed that she needed to do some

research and that it was a personal choice whether or not to get vaccinated; the Chief Commercial Officer responded that he respected Brode’s choice, but that Xeris might not be the place for her. [3] ¶ 13. Brode asked one person in Xeris’s HR about “accommodations” and was directed to submit her request to other individuals in the group. [3] ¶ 14. Brode then wrote to those HR individuals and said, “I do have a religious exemption” and asked how to submit her request for an exemption. [3] at 9.

Brode was told that she could submit a written request for a religious exemption. [3] at 10. Brode submitted an email explaining that she opposed the COVID-19 mRNA

1 Bracketed numbers refer to entries on the district court docket and page numbers refer to the CM/ECF header placed at the top of filings. When a document has numbered paragraphs, I cite to the paragraph, for example [1] ¶ 1. The facts are taken from Brode’s complaint, [1] and attached affidavit, [3]. Written instruments attached to the complaint are part of the complaint. Fed. R. Civ. P. 10(c). Brode incorporates her affidavit into the complaint, [1] ¶ 48, so it can be considered when ruling on a motion to dismiss. vaccines that were “produced or generated from aborted fetal cell lines.” [3] at 11. She also stated that “coerced medical treatment” was contrary to her religious faith. Id. On November 12, 2021, Xeris’s HR department informed Brode that it had

approved her request for a religious exemption “and based on the nature of your current position and the direct threat of harm you pose to other employees, customers and vendors,” her accommodation would be to “be placed on a temporary, unpaid personal leave of absence beginning November 29, 2021 … until the earlier of either the Company ending its vaccination requirement or you becoming fully vaccinated.” [3] at 13. Brode responded in writing that the accommodation appeared to be a

termination of her employment, she did “not intend to voluntarily sever [her] relationship with Xeris” and she would be willing to work while wearing masks, observing client medical protocols, and being tested weekly. [3] at 14–15. Xeris responded through its Chief Legal Counsel, Beth Hecht, who said Xeris did not believe Brode had stated a legally cognizable claim for a religious accommodation. [3] at 16. The company granted an accommodation by permitting a temporary, unpaid leave of absence and denied Brode’s request for the other accommodations. Id. Brode

was placed on leave on November 29, 2021. [3] ¶ 20. Nearly four months later, in March 2022, Brode submitted a “Notice of Discrimination and Harassment Based upon Disability” to Xeris via email. [3] ¶ 21. Brode also submitted a charge of discrimination and retaliation to the EEOC. [3] ¶ 22. In early April 2022, Brode had a phone conversation with Xeris about her EEOC charge and was sent a separation agreement. [3] ¶ 23. The cover letter stated that Xeris had decide to terminate her employment because of the merger between Strongbridge and Xeris. [3] at 31. The Separation Agreement provided that Xeris would give Brode a severance package in exchange for a signed release and

withdrawal of her EEOC charge. [3] at 32. Brode ultimately declined to sign the Separation Agreement and her termination was made effective April 22, 2022. [3] ¶¶ 30–31. I. Analysis A.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Swanson v. Citibank, N.A.
614 F.3d 400 (Seventh Circuit, 2010)
Heller Financial, Inc. v. Midwhey Powder Co., Inc.
883 F.2d 1286 (Seventh Circuit, 1989)
Casna v. City of Loves Park
574 F.3d 420 (Seventh Circuit, 2009)
Ronald Shell v. Burlington Northern Santa Fe R
941 F.3d 331 (Seventh Circuit, 2019)
Tamika Graham v. Board of Education of the City
8 F.4th 625 (Seventh Circuit, 2021)
Joanne Kaminski v. Elite Staffing, Inc.
23 F.4th 774 (Seventh Circuit, 2022)
Linda Brooks v. Avancez
39 F.4th 424 (Seventh Circuit, 2022)
Erin McHale v. Denis McDonough
41 F.4th 866 (Seventh Circuit, 2022)
Koty v. Dupage Cnty.
900 F.3d 515 (Seventh Circuit, 2018)
Tate v. SCR Medical Transportation
809 F.3d 343 (Seventh Circuit, 2015)
Monroe v. Indiana Department of Transportation
871 F.3d 495 (Seventh Circuit, 2017)
Frakes v. Peoria School District No. 150
872 F.3d 545 (Seventh Circuit, 2017)
Thomas Barwin v. Village of Oak Park
54 F.4th 443 (Seventh Circuit, 2022)
Kristie Alley v. Penguin Random House
62 F.4th 358 (Seventh Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Brode v. Xeris Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/brode-v-xeris-pharmaceuticals-inc-ilnd-2023.